← FDA Drug Approvals (Drugs@FDA)
TRI-LO-LINYAH
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2022-09-02
Drug application
- FDA Application #
ANDA090541- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TRI-LO-LINYAH
- Generic name
- Norgestimate
- Active ingredients
- NORGESTIMATE; ETHINYL ESTRADIOL
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- NOVAST LABS
- First approval
- 2022-09-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown